Information about Medical Capital Investments II
My details
*
*
*

Medical Capital Investments II (SRL)

77693558

De Heerenhof 5, 3343 EZ HENDRIK-IDO-AMBACHT

Company information

Status
Active

KVK number

77693558

VAT Number

Established
24-03-2020
Last balance sheet year
2022
Company size
Micro 0 FTE
RSIN number
861101248
Principal activity
Activiteiten van financiële holdings
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Medical Capital Investments II

2022 2021 2020
Equity € 186.188 -54 % € 405.270 174 % € 147.869
Employees 0 0 0

Frequently asked questions

What is the KVK number of Medical Capital Investments II?
The KVK number of Medical Capital Investments II is 77693558
What is the VAT number of Medical Capital Investments II?
Log in or start a free trial to view the VAT number.
Wat is the PEPPOL ID of Medical Capital Investments II?
There is no information available about the PEPPOL ID of Medical Capital Investments II or the company is not yet registered on the PEPPOL network.
When was Medical Capital Investments II founded?
Medical Capital Investments II was founded on 24-03-2020.
What is the address of Medical Capital Investments II?
The current registered office of Medical Capital Investments II is located at De Heerenhof 5, 3343 EZ HENDRIK-IDO-AMBACHT.
When was the last time Medical Capital Investments II filed their annual financial statements?
The most recent financial statements of Medical Capital Investments II were filed on 31-12-2022.
How many employees does Medical Capital Investments II have?
There are currently no employees working at Medical Capital Investments II or no workforce information is available.
What is the annual turnover of Medical Capital Investments II?
There is no turnover available for Medical Capital Investments II.

Sources